What Is Tirzepatide and Why Does It Cost So Much?
Tirzepatide is the active ingredient in two FDA-approved medications: Mounjaro (approved for type 2 diabetes) and Zepbound (approved for chronic weight management). Both are manufactured by Eli Lilly and belong to a class of drugs called dual GIP/GLP-1 receptor agonists — a mechanism that makes them among the most effective medications ever studied for blood sugar control and weight loss.
The high list price reflects Lilly's significant R&D investment, the complexity of manufacturing injectable biologics, and the absence of generic competition. Tirzepatide's patents are not expected to expire until the early 2030s, meaning list prices are unlikely to fall dramatically in the near term. However, the actual price most patients pay is substantially lower than the list price, thanks to savings programs, insurance coverage, and discount services.
Tirzepatide List Price in 2026
The official list prices (wholesale acquisition cost) for a one-month supply as of 2026 are:
| Medication | Indication | List Price / Month |
|---|---|---|
| Mounjaro 2.5 mg | Type 2 diabetes | $1,112 |
| Mounjaro 5 mg – 15 mg | Type 2 diabetes | $1,112 |
| Zepbound 2.5 mg pen | Weight management | $1,086 |
| Zepbound 5 mg – 15 mg pen | Weight management | $1,086 |
| Zepbound 2.5 mg vial (LillyDirect) | Weight management | $299 |
| Zepbound 5 mg vial (LillyDirect) | $399 | |
| Zepbound 7.5 mg–15 mg vial (LillyDirect) | $449 |
The vial pricing through LillyDirect represents a major breakthrough for cash-paying patients. In December 2025, Eli Lilly lowered the self-pay price of Zepbound single-dose vials to $299–$449 per month — a reduction of 60–70% from the pen list price — making tirzepatide accessible to patients without insurance coverage for the first time at a meaningful scale.
How Much Does Tirzepatide Cost With Insurance?
Insurance coverage for tirzepatide depends entirely on the indication and your specific plan:
For type 2 diabetes (Mounjaro): Most commercial insurance plans cover Mounjaro when prescribed for diabetes. Patients with commercial insurance who use the Lilly Savings Card may pay as little as $25 per month for a 1- or 3-month supply. Medicare Part D covers Mounjaro for diabetes, with out-of-pocket costs capped at $2,100 for the full year in 2026 under the Inflation Reduction Act.
For weight management (Zepbound): Insurance coverage is more variable. As of 2026, roughly 40% of commercial plans cover Zepbound for obesity. Patients with coverage and a commercial plan can use the Lilly Savings Card to pay as little as $25/month. Patients whose insurance does not cover Zepbound can use the savings card to pay as low as $499/month for pens or $299–$449/month for vials via LillyDirect.
Medicare: Medicare does not currently cover GLP-1 medications prescribed solely for weight loss. However, if you have a qualifying comorbidity (type 2 diabetes, cardiovascular disease), coverage may apply.
Tirzepatide Cost Without Insurance: All Your Options
If you do not have insurance coverage for tirzepatide, you have four main pathways to reduce your cost:
1. LillyDirect Self-Pay Vials ($299–$449/month)
The lowest-cost option for uninsured patients is Zepbound single-dose vials purchased directly through LillyDirect. Prices are:
- 2.5 mg vial: $299/month
- 5 mg vial: $399/month
- 7.5 mg, 10 mg, 12.5 mg, 15 mg vials: $449/month
Note that vials require self-injection with a separate syringe, which some patients find less convenient than the pre-filled pen. However, the $600–$700 monthly savings compared to pen list price makes this the most cost-effective option for most uninsured patients.
2. Prescription Discount Services ($499–$600/month)
Services like RxGo, GoodRx, and Blink Health negotiate discounted rates with pharmacy networks. For Zepbound pens, discount prices typically range from $499 to $600/month depending on the pharmacy and dose. For Mounjaro, discount prices are similar. These services are free to use and require no enrollment — simply present the coupon at the pharmacy counter.
Use the free RxGo savings tool to compare tirzepatide prices at pharmacies near you →
3. Manufacturer Savings Card (With Commercial Insurance)
If you have commercial insurance that does not cover tirzepatide, the Lilly Savings Card can reduce your cost to $499/month for Zepbound pens. This card is not available to Medicare or Medicaid beneficiaries.
4. Patient Assistance Programs
Lilly's Lilly Cares Foundation provides free medication to patients who meet income eligibility requirements (typically below 400% of the federal poverty level) and lack adequate insurance coverage. Applications are processed through your prescribing physician.
Mounjaro vs. Zepbound: Which Is Cheaper?
Both medications contain tirzepatide, but they are approved for different indications and priced differently in the self-pay market:
| Factor | Mounjaro | Zepbound |
|---|---|---|
| Indication | Type 2 diabetes | Chronic weight management |
| List price (pen) | $1,112/month | $1,086/month |
| Self-pay vial price | Not available | $299–$449/month (LillyDirect) |
| Insurance coverage | Broader (diabetes indication) | Less consistent (obesity indication) |
| Savings card minimum | $25/month (with coverage) | $25/month (with coverage) |
For patients without insurance, Zepbound vials via LillyDirect are significantly cheaper than Mounjaro. For patients with diabetes and commercial insurance, both medications may be available at $25/month with the savings card.
See our full Mounjaro vs. Zepbound comparison → for a detailed breakdown of efficacy, dosing, and side effect profiles.
Does Insurance Cover Tirzepatide?
Whether your insurance covers tirzepatide depends on three factors: your plan's formulary, the indication (diabetes vs. weight loss), and whether prior authorization is required.
Step 1: Check your formulary. Log into your insurance portal or call the member services number on your card and ask whether Mounjaro (for diabetes) or Zepbound (for weight management) is on your formulary and at what tier.
Step 2: Confirm the indication. Mounjaro is more likely to be covered than Zepbound because diabetes treatment has broader insurance support than obesity treatment. If you have type 2 diabetes, ask your doctor to prescribe Mounjaro rather than Zepbound.
Step 3: Prepare for prior authorization. Most plans that cover tirzepatide require prior authorization, which means your doctor must submit documentation showing you meet clinical criteria (typically a BMI threshold and/or failed first-line treatments). This process takes 5–10 business days.
How to Save on Tirzepatide: Quick Summary
The fastest ways to reduce your tirzepatide cost in 2026:
- Uninsured and using for weight loss: Order Zepbound vials through LillyDirect at $299–$449/month — the lowest available cash price.
- Insured but not covered: Use the Lilly Savings Card to pay $499/month for pens, or switch to LillyDirect vials.
- Insured and covered: Use the Lilly Savings Card to pay as little as $25/month.
- Any situation: Use a free prescription discount service like RxGo to compare prices across all pharmacies near you before filling your prescription.
- Low income: Apply to the Lilly Cares Foundation for free medication if you meet income eligibility.
Frequently Asked Questions
Is there a generic tirzepatide? No. Tirzepatide is a biologic medication protected by patents until the early 2030s. Generic versions (biosimilars) are not expected to be available before 2033–2035.
Can I get compounded tirzepatide? Compounded tirzepatide was widely available in 2024–2025 when Mounjaro and Zepbound were on the FDA shortage list. As of early 2026, the FDA has removed tirzepatide from the shortage list, which means most compounding pharmacies are no longer legally permitted to compound it. Patients currently on compounded tirzepatide should transition to the brand-name product.
Does GoodRx work for tirzepatide? Yes, GoodRx and other discount services work for tirzepatide at most retail pharmacies. However, for uninsured patients, LillyDirect's vial pricing ($299–$449/month) is typically lower than GoodRx coupon prices for pens ($499–$600/month).
How much does tirzepatide cost per dose? At LillyDirect vial pricing, the cost per dose ranges from $299 (2.5 mg) to $449 (7.5 mg–15 mg) per month. Each monthly supply contains 4 doses (one injection per week).
Save up to 80% on this medication
Use a free RxGo discount card at 67,000+ pharmacies — no sign-up, no insurance needed.
About the Author
RxGuide Editorial Team, PharmD, RPh
Clinical Pharmacist & Medical Writer
The RxGuide editorial team is composed of licensed pharmacists and clinical medical writers with expertise in pharmacology, drug safety, and patient education. All clinical content is reviewed against current FDA labeling, peer-reviewed literature, and established clinical guidelines before publication.
Related Articles
Wegovy vs. Zepbound: Which GLP-1 Weight Loss Drug Is More Effective?
Wegovy and Zepbound are both FDA-approved injectable medications for weight loss, but Zepbound produces 47% more weight loss in head-to-head trials.
Mounjaro vs. Zepbound: Same Drug, Two FDA Approvals — Which Is Right for You?
Mounjaro and Zepbound both contain tirzepatide, but are FDA-approved for different conditions. Learn the key differences in indications, cost, insurance coverage, and when to choose each drug.
Mounjaro vs. Ozempic: Which GLP-1 Drug Is Right for You?
Get the RxGo app — free prescription discounts on the go
Works at 67,000+ pharmacies · No membership needed